Director, Clinician Medical Monitor
Vaccine Research and Development, Pfizer, USA
Disclosure(s): Pfizer, Inc.: salary, Stocks/Bonds (Public Company)
Dr. Kumar Ilangovan, MD, MSPH, MMCi, FACP, FAAP, is a Director and Clinician Medical Monitor of Vaccines Clinical Research and Development at Pfizer, Inc. He is a study clinician and medical monitor on vaccine clinical trials. He has worked on clinical and applied research for over ten years and practiced clinically as a Med-Peds Primary Care Physician. In his current role, he is accountable for providing medical and scientific expertise and oversight for Clinical Trials. Before his current role, he served as medical director for a pediatric CRO and a medical monitor on Phase I - IV interventional trials for neonates through adolescents. His applied research experience included health services research focused on cervical and breast cancer prevention.